Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of Azelaic acid (cas 123-99-9)
-
Add time:10/01/2019 Source:sciencedirect.com
The objective of this study is to investigate the effect of 1,4-cyclohexanediol as a retardant on the percutaneous absorption and penetration of azelaic acid. Hairless rat skin was mounted on Franz diffusion cells and treated with topical formulations containing solubilized azelaic acid with and without 1,4-cyclohexanediol. The skin was separated into stratum corneum and the deeper skin layers. The azelaic acid collected in receptor medium and each layer at the end of each time point was extracted and quantified. A significant decrease in flux across the skin suggests a penetration retardation effect of 1,4-cyclohexanediol (42.50 μg/cm2/h in the presence of vs. 76.25 μg/cm2/h in the absence of) at active loading level of 1.13 mg/cm2. The penetration retardation effect was also observed at higher active loading level (2.82 mg/cm2). Furthermore, presence of 1,4-cyclohexanediol in the topical formulation did not reduce the skin and epidermal retention of azelaic acid, suggesting its potential use in the development of superior topical formation for reducing potential systematic side effect while maintaining therapeutic efficiency.
We also recommend Trading Suppliers and Manufacturers of Azelaic acid (cas 123-99-9). Pls Click Website Link as below: cas 123-99-9 suppliers
Prev:Olfactory receptor Olfr544 responding to Azelaic acid (cas 123-99-9) regulates glucagon secretion in α-cells of mouse pancreatic islets
Next:Traumatic acid toxicity mechanisms in human breast cancer MCF-7 cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Olfactory receptor Olfr544 responding to Azelaic acid (cas 123-99-9) regulates glucagon secretion in α-cells of mouse pancreatic islets09/27/2019
- Molecular determinants of the olfactory receptor Olfr544 activation by Azelaic acid (cas 123-99-9)09/26/2019
- Untargeted metabolomics analysis reveals dynamic changes in Azelaic acid (cas 123-99-9)- and salicylic acid derivatives in LPS-treated Nicotiana tabacum cells09/25/2019
- Nanostructured gel for topical delivery of Azelaic acid (cas 123-99-9): Designing, characterization, and in-vitro evaluation09/24/2019
- New effective Azelaic acid (cas 123-99-9) liposomal gel formulation of enhanced pharmaceutical bioavailability09/10/2019
- Preparation of in situ hydrogels loaded with Azelaic acid (cas 123-99-9) nanocrystals and their dermal application performance study09/09/2019
- Preparation of antibacterial TiO2 particles by hybridization with Azelaic acid (cas 123-99-9) for applications in cosmetics09/08/2019
-
Health and Chemical more >